DNA-Customized Genotrim [Neuronal Dopamine Release Activator] Results in Significant Reductions in Weight, Appetite, Sugar Cravings in an Obese Population in the Dietary Investigation to Evaluate Treatments (DIET) Pilot Study. Nutrigenomic Correlates of Reward Deficiency Syndrome (RDS)